Navigation Links
New Cimzia® (certolizumab pegol) Data Show a Significant, Rapid Clinical Response and Reduced Disease Activity Among Diverse Patient Populations With Active Rheumatoid Arthritis (RA)
Date:11/9/2010

rt FailureCases of worsening congestive heart failure (CHF) and new onset CHF have been reported with TNF blockers.  Certolizumab pegol has not been formally studied in patients with CHF.  Exercise caution when using certolizumab pegol in patients who have heart failure and monitor them carefully.

HypersensitivitySymptoms compatible with hypersensitivity reactions, including angioedema, dyspnea, hypotension, rash, serum sickness, and urticaria, have been reported rarely following certolizumab pegol administration.  If such reactions occur, discontinue further administration of certolizumab pegol and institute appropriate therapy.

Hepatitis B ReactivationUse of TNF blockers, including certolizumab pegol, may increase the risk of reactivation of hepatitis B virus (HBV) in patients who are chronic carriers of this virus. Some cases have been fatal. Evaluate patients at risk for HBV infection for prior evidence of HBV infection before initiating certolizumab pegol therapy.  Exercise caution in prescribing certolizumab pegol for patients identified as carriers of HBV, with careful evaluation and monitoring prior to and during treatment. In patients who develop HBV reactivation, discontinue certolizumab pegol and initiate effective anti-viral therapy with appropriate supportive treatment.

Neurologic ReactionsUse of TNF blockers, including certolizumab pegol, has been associated with rare cases of new onset or exacerbation of clinical symptoms and/or radiographic evidence of central nervous system demyelinating disease, including multiple sclerosis, and with peripheral demyelinating disease, including Guillain-Barre syndrome. Rare cases of neurological disorders, including seizure disorder, optic neuritis, and peripheral neuropathy have been reported in patients treated with certolizumab pegol. Exercise caution in considering the use of certolizumab pegol in patients with the
'/>"/>

SOURCE UCB
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Rapid and Long-term Clinical Responses Observed in Rheumatoid Arthritis Patients Taking Cimzia® (certolizumab pegol), According to Data Being Highlighted During ACR Meeting
2. UCB Presents Growing Body of Long-term Efficacy Data at ACG 2010 Meeting to Further Support Treatment with Cimzia® (certolizumab pegol) in Multiple Patient Populations with Moderate to Severe Crohns Disease
3. Long-Term Data on Cimzia® (certolizumab pegol) for Moderate to Severe Crohns Disease to be Highlighted at ACG Meeting
4. New Data Show CIMZIA(R) (certolizumab pegol) Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients
5. CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years
6. CIMZIA(R) (Certolizumab Pegol) Provides Long-Term Benefit Without Dose Escalation in Crohns Disease Patients
7. CIMZIA(R) (certolizumab pegol) Reduces Intestinal Lesions and Induces Endoscopic Improvement in Crohns Patients
8. CIMZIA(R) (certolizumab pegol), Significantly Reduces Structural Damage and Rheumatoid Arthritis Signs & Symptoms for Up to One Year
9. Marken Rapidly Responds to Global Supply Chain Security Measures
10. Biosimilar Erosion of Branded ESA Market Share Will be More Rapid in the U.S. Than in Europe
11. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... YORK , August 31, 2015 ... they have entered into an exclusive licensing agreement for ... in the estimated $300 million USD veterinary dermatology market, ... (ultramicronized palmitoylethanolamide) to support healthy skin in dogs and ... Italy , and has been received ...
(Date:8/31/2015)... Aug. 31, 2015 Research and Markets ... the "Prescription Pain Drugs - Including Opioid, ... Global Markets, Competitors and Opportunities: 2015 - 2020 ... Pain is defined as an ... or potential tissue damage. At some point, everyone ...
(Date:8/28/2015)... , Aug. 28, 2015  Delays in the ... can slow down the decision-making process, resulting in ... absolutely critical for biopharmaceutical companies to develop a ... process for quicker and more meaningful insights. ... Practices, LLC, nearly three-quarters of benchmarked study participants ...
Breaking Medicine Technology:Premune Broadens Portfolio With Novel Innovet Skin Health Product 2Premune Broadens Portfolio With Novel Innovet Skin Health Product 3Premune Broadens Portfolio With Novel Innovet Skin Health Product 4Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 2Prescription Pain Drugs Including Opioid, Anticonvulsant, Injectable/ Inhaled, Topical/ Transdermal, Medical Marijuana - 2015-2020 Analysis and Forecasts 3Expediting the Pharmaceutical Market Research Process for Faster Insights 2
... LodgeNet Healthcare , a division of ... integrated patient engagement solutions, announced today the availability ... Patient-Facing Technologies to Improve the Quality of Patient ... to patient engagement that incorporates television-based technology will ...
... Health, one of the top 25 independent healthcare communications ... in the Southwest, won a Manny Award for best ... a national competition honoring creative excellence in healthcare advertising. ... Sound Surgical Technologies, VASER® body shaping systems. Winners were ...
Cached Medicine Technology:LodgeNet Healthcare Whitepaper Explores Key Role of Patient/Family Engagement in Health Reform/Meaningful Use 2LodgeNet Healthcare Whitepaper Explores Key Role of Patient/Family Engagement in Health Reform/Meaningful Use 3LodgeNet Healthcare Whitepaper Explores Key Role of Patient/Family Engagement in Health Reform/Meaningful Use 4LodgeNet Healthcare Whitepaper Explores Key Role of Patient/Family Engagement in Health Reform/Meaningful Use 5HCB Health Wins Manny Award for Best Medical Device Campaign 2
(Date:8/31/2015)... ... August 31, 2015 , ... DR. ... Luciana Lagana (aka Dr. Luciana) received a total of three Silver Medal ... Documentary, and Best (Dis)ability Film. Dr. Luciana co-wrote and co-produced this pilot with ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... primary care, is enhancing its existing presence in Tennessee with the opening of ... is the company’s second in Knoxville, sixteenth in Tennessee, and 148th in the ...
(Date:8/31/2015)... Pittsburgh, PA (PRWEB) , ... August 31, 2015 , ... ... that they’ll have a higher body mass index and bigger waist circumference, a 15-year ... , The association did not hold in later years, indicating that young adulthood is ...
(Date:8/31/2015)... (PRWEB) , ... August 31, 2015 , ... With baseball ... play-offs and the World Series will dominate the sports world. Fans desire nothing more ... advance to the final series. For children, especially those who are too young to ...
(Date:8/31/2015)... ... August 31, 2015 , ... Castle Dermatology Institute now welcomes ... Ghasri is a graduate of the University of California, Los Angeles. He graduated summa ... the University of California, Irvine Medical School. As a nationally recognized Regents Scholar, Dr. ...
Breaking Medicine News(10 mins):Health News:Actor/Writer/Director/Psychology Professor Luciana Lagana Receives Three Wins at the 2015 Global Independent Film Awards for the TV Pilot Dr. Luciana on Aging and Falling 2Health News:State-of-the-Art Urgent Care Facility Opening in Knoxville 2Health News:Watching More TV as a Young Adult Predicts Obesity 2Health News:Watching More TV as a Young Adult Predicts Obesity 3Health News:New Children's Baseball Series Offers Young Fans a Way to Celebrate the World Series 2Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2
... 13 Quintiles,Transnational Corp. today announced that its ... College of American Pathologists (CAP)., The central ... the first,quarter of 2007. The facility has seen ... capabilities to a growing test menu., "CAP ...
... a press conference hosted by New York,Attorney General Andrew ... probe of 16 national health insurers regarding an alleged,scheme ... The following is,attributable to Nancy H. Nielsen, M.D., Ph.D., ... York Attorney General Andrew,Cuomo calls into question the validity ...
... of Alberta study, analyzing a sample of over 275,000 ... in physical activity, one size does not fit all. ... when deciding how and if a person wants to ... at the University of Alberta. It is clear that ...
... NEW YORK, Feb. 13 Today, more than ... challenges from,all sides. Internally, the pressure to fill ... generics demand new outcomes from,pharmaceutical marketing and sales ... regulatory (e.g. post-approval monitoring),legislative, and patent issues continue ...
... VALLEY, Calif., Feb. 13 Sun Busters(R), the swim,wear ... and providing,the ultimate in sun protection now sports a ... of Recommendation! Sun Busters is proud,to announce that they ... products that have a UPF of 50+. UPF is ...
... Feb. 13 Statistics released by the,Centers for Disease ... American children is affected by autism. In Georgia, these ... that is rising in,prevalence with alarming speed. It is ... Georgia are affected by autism, a disorder of,unknown origin ...
Cached Medicine News:Health News:Quintiles Central Laboratory in India Receives CAP Certification 2Health News:AMA Commends N.Y. Investigation of Health Insurers 2Health News:Study: When it comes to physical activity, one size does not fit all 2Health News:Legislative and Regulatory Outlook - 2009 and Beyond for Pharma, Biotech Players 2Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 2Health News:Sun Busters(R) Now Sports The Skin Cancer Foundation's Seal of Recommendation 3Health News:2008 Georgia Walk for Autism Supporters Gather in Atlanta for Kick-Off Dinner 2
... The RoamAlert Integrity system builds ... ECO. All door controllers in the ... computer running a standard Windows® operating ... the use of a personal computer, ...
... The RoamAlert ECO system ... or several doors. Each exit ... controller. When a resident wearing ... door, the door will lock; ...
... uses RFID to gather patient ... departments such as surgical and ... updates of patient location to ... care events have occurred and ...
... Identification (RFID) helps incorporate people and intelligent ... healthcare value chain. The power of RFID ... automate and optimize business activities in support ... pharmaceutical inventories, RFID offers tremendous potential to ...
Medicine Products: